Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Ally Bridge Group (NY) LLC (CIK 1822947) reported $123.8M across 20 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: SLNO ($13.4M, 10.82%), PRAX ($10.6M, 8.54%), NERV ($10.0M, 8.06%), OVID ($6.3M, 5.05%), CMPS ($5.8M, 4.67%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SLNO | SOLENO THERAPEUTICS INC | $13.4M | 10.82% | 400,000 | Added |
| 2 | PRAX | PRAXIS PRECISION MEDICINES I | $10.6M | 8.54% | 32,810 | Added |
| 3 | NERV | MINERVA NEUROSCIENCES INC | $10.0M | 8.06% | 1.7M | Hold |
| 4 | OVID | OVID THERAPEUTICS INC | $6.3M | 5.05% | 2.8M | Added |
| 5 | CMPS | COMPASS PATHWAYS PLC | $5.8M | 4.67% | 1.0M | Trimmed |
| 6 | TARS | TARSUS PHARMACEUTICALS INC | $5.7M | 4.58% | 80,859 | New |
| 7 | SLDB | SOLID BIOSCIENCES INC | $5.5M | 4.46% | 766,974 | Added |
| 8 | CMPX | COMPASS THERAPEUTICS INC | $5.3M | 4.27% | 1.0M | New |
| 9 | PMN | PROMIS NEUROSCIENCES INC | $5.3M | 4.25% | 414,219 | Added |
| 10 | EWTX | EDGEWISE THERAPEUTICS INC | $5.1M | 4.10% | 161,000 | Trimmed |
| 11 | QURE | UNIQURE NV | $4.9M | 3.96% | 300,000 | Added |
| 12 | EPRX | EUPRAXIA PHARMACEUTICALS INC | $4.8M | 3.86% | 660,375 | Added |
| 13 | CTMX | CYTOMX THERAPEUTICS INC. | $4.2M | 3.42% | 900,000 | New |
| 14 | IVA | INVENTIVA SA | $4.1M | 3.34% | 745,300 | Trimmed |
| 15 | CATX | PERSPECTIVE THERAPEUTICS INC | $3.9M | 3.12% | 926,557 | New |
| 16 | ABVX | ABIVAX SA | $3.8M | 3.03% | 33,712 | Trimmed |
| 17 | ALMS | ALUMIS INC | $3.7M | 2.97% | 166,959 | New |
| 18 | URGN | UROGEN PHARMA LTD | $3.6M | 2.94% | 202,124 | New |
| 19 | CAPR | CAPRICOR THERAPEUTICS INC | $3.5M | 2.80% | 113,899 | New |
| 20 | MAZE | MAZE THERAPEUTICS INC | $3.0M | 2.41% | 100,000 | New |
| 21 | WHWK | WHITEHAWK THERAPEUTICS INC | $2.8M | 2.28% | 817,939 | Hold |
| 22 | IKT | INHIBIKASE THERAPEUTICS INC | $2.2M | 1.80% | 1.3M | New |
| 23 | REPL | REPLIMUNE GROUP INC | $1.9M | 1.53% | 246,900 | Trimmed |
| 24 | ANTX | AN2 THERAPEUTICS INC | $1.8M | 1.45% | 526,315 | New |
| 25 | RLMD | RELMADA THERAPEUTICS INC | $1.5M | 1.18% | 210,525 | New |
Source: SEC Form 13F filings · as of 2026-03-31